Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development of a rapid and comprehensive genomic profiling test supporting diagnosis and research for gliomas.
Nakashima T, Yamamoto R, Ohno M, Sugino H, Takahashi M, Funakoshi Y, Nambu S, Uneda A, Yanagisawa S, Uzuka T, Arakawa Y, Hanaya R, Ishida J, Yoshimoto K, Saito R, Narita Y, Suzuki H. Nakashima T, et al. Among authors: ishida j. Brain Tumor Pathol. 2024 Apr;41(2):50-60. doi: 10.1007/s10014-023-00476-3. Epub 2024 Feb 8. Brain Tumor Pathol. 2024. PMID: 38332448
Combined simultaneous endoscopic endonasal and transcranial surgery using high-definition three-dimensional exoscope for malignant tumors of the anterior skull base.
Makihara S, Otani Y, Uraguchi K, Shimizu A, Murai A, Higaki T, Akisada N, Fujimoto S, Makino T, Ishida J, Fujii K, Yasuhara T, Ota T, Matsumoto H, Ando M. Makihara S, et al. Among authors: ishida j. Head Neck. 2024 May;46(5):1074-1082. doi: 10.1002/hed.27724. Epub 2024 Mar 7. Head Neck. 2024. PMID: 38450867
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma.
Fujita N, Bondoc A, Simoes S, Ishida J, Taccone MS, Luck A, Srikanthan D, Siddaway R, Levine A, Sabha N, Krumholtz S, Kondo A, Arai H, Smith C, McDonald P, Hawkins C, Dedhar S, Rutka J. Fujita N, et al. Among authors: ishida j. Brain Tumor Pathol. 2024 Oct;41(3-4):117-131. doi: 10.1007/s10014-024-00493-w. Epub 2024 Sep 24. Brain Tumor Pathol. 2024. PMID: 39316272
Efficacy and safety of carmustine wafers, followed by radiation, temozolomide, and bevacizumab therapy, for newly diagnosed glioblastoma with maximal resection.
Kanamori M, Shibahara I, Shimoda Y, Akiyama Y, Beppu T, Ohba S, Enomoto T, Ono T, Mitobe Y, Hanihara M, Mineharu Y, Ishida J, Asano K, Yoshida Y, Natsumeda M, Nomura S, Abe T, Yonezawa H, Katakura R, Shibui S, Kuroiwa T, Suzuki H, Takei H, Matsushita H, Saito R, Arakawa Y, Sonoda Y, Hirose Y, Kumabe T, Yamaguchi T, Endo H, Tominaga T. Kanamori M, et al. Among authors: ishida j. Int J Clin Oncol. 2025 Jan;30(1):51-61. doi: 10.1007/s10147-024-02650-9. Epub 2024 Nov 11. Int J Clin Oncol. 2025. PMID: 39527165 Free PMC article. Clinical Trial.
Myeloid Cells Induce Infiltration and Activation of B Cells and CD4+ T Follicular Helper Cells to Sensitize Brain Metastases to Combination Immunotherapy.
Ninomiya T, Kemmotsu N, Mukohara F, Magari M, Miyamoto A, Ueda Y, Ishino T, Nagasaki J, Fujiwara T, Yamamoto H, Hayashi H, Tachibana K, Ishida J, Otani Y, Tanaka S, Toyooka S, Okamoto I, Togashi Y. Ninomiya T, et al. Among authors: ishida j. Cancer Res. 2025 Jan 13. doi: 10.1158/0008-5472.CAN-24-2274. Online ahead of print. Cancer Res. 2025. PMID: 39804971
Treatment Outcomes of Tyrosine Kinase Inhibitors and Durvalumab Plus Tremelimumab After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma.
Ishihara N, Komatsu S, Yano Y, Fujishima Y, Ishida J, Kido M, Gon H, Fukushima K, Urade T, Yoshida T, Tai K, Arai K, Yanagimoto H, Toyama H, Matsuura T, Tada T, Kodama Y, Fukumoto T. Ishihara N, et al. Among authors: ishida j. Anticancer Res. 2025 Jan;45(1):251-260. doi: 10.21873/anticanres.17412. Anticancer Res. 2025. PMID: 39740814
Comparative analysis of intraoperative MRI and early postoperative MRI findings in glioma surgery patients.
Otani Y, Higaki F, Fujii K, Ishida J, Shimazu Y, Hirano S, Kemmotsu N, Suruga Y, Imoto R, Mizuta R, Kegoya Y, Inoue Y, Umeda T, Hokama M, Yasuhara T, Hiraki T, Kurozumi K, Ichikawa T, Tanaka S, Date I. Otani Y, et al. Among authors: ishida j. J Neurosurg. 2024 Dec 27:1-9. doi: 10.3171/2024.7.JNS24784. Online ahead of print. J Neurosurg. 2024. PMID: 39729586
561 results